North America Injection Pen Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Injection Pen Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Injection Pen Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Injection Pen Market Regional Analysis

6.2 North America Injection Pen Market Revenue 2020-2028 (US$ Million)

6.3 North America Injection Pen Market Forecast Analysis

7. North America Injection Pen Market Analysis – by Type

7.1 Disposable Injection Pens

7.1.1 Overview
7.1.2 Disposable Injection Pens: North America Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Reusable Injection Pens

7.2.1 Overview
7.2.2 Reusable Injection Pens: North America Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. North America Injection Pen Market Analysis – by Therapy

8.1 Diabetes

8.1.1 Overview
8.1.2 Diabetes: North America Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Growth Hormone Therapy

8.2.1 Overview
8.2.2 Growth Hormone Therapy: North America Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.3 Autoimmune Diseases

8.3.1 Overview
8.3.2 Autoimmune Diseases: North America Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.4 Fertility

8.4.1 Overview
8.4.2 Fertility: North America Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.5 Cancer

8.5.1 Overview
8.5.2 Cancer: North America Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.6 Others Therapy

8.6.1 Overview
8.6.2 Others Therapy: North America Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. North America Injection Pen Market Analysis – by End User

9.1 Hospitals and Clinics

9.1.1 Overview
9.1.2 Hospitals and Clinics: North America Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Home Care

9.2.1 Overview
9.2.2 Home Care: North America Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. North America Injection Pen Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Injection Pen Market Breakdown, by Key Country, 2023 and 2028 (%)
10.2.1.1 North America Injection Pen Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Injection Pen Market Breakdown, by Type
10.2.1.1.2 US: North America Injection Pen Market Breakdown, by Therapy
10.2.1.1.3 US: North America Injection Pen Market Breakdown, by End User

10.2.1.2 Canada: North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Injection Pen Market Breakdown, by Type
10.2.1.2.2 Canada: North America Injection Pen Market Breakdown, by Therapy
10.2.1.2.3 Canada: North America Injection Pen Market Breakdown, by End User

10.2.1.3 Mexico : North America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Injection Pen Market Breakdown, by Type
10.2.1.3.2 Mexico : North America Injection Pen Market Breakdown, by Therapy
10.2.1.3.3 Mexico : North America Injection Pen Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 AstraZeneca Plc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Becton Dickinson and Co

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Eli Lilly and Co

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Gerresheimer AG

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Haselmeier GmbH

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Merck KGaA

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Novo Nordisk AS

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Owen Mumford Ltd

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Sanofi SA

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Teva Pharmaceutical Industries Ltd

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Injection Pen Market

Analysis By Type (Disposable Injection Pens and Reusable Injection Pens), Therapy (Diabetes, Growth Hormone Therapy, Autoimmune Diseases, Fertility, Cancer, and Others Therapy), and End User (Hospitals and Clinics, Home Care, and Others)